Company: EPR-PE
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0001045450-25-000068
Chunk: 60

Company: EPR PROPERTIES
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 60
---
 the aggregate grant date fair value of the nonvested restricted common shares.

(2) Amounts reflect the aggregate grant date fair value of such awards, computed in accordance with FASB ASC Topic 718. For policies used in determining these values, refer to Note 15 of the Company’s consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC. These amounts reflect an accounting expense and do not necessarily correspond to the actual value that may be realized by the NEOs.

(3) Amounts include: (i) the aggregate grant date fair value of nonvested restricted performance share units issued pursuant to the LTI; (ii) the aggregate grant date fair value of nonvested restricted common shares issued pursuant to the LTI; and (iii) the incremental aggregate grant date fair value of nonvested restricted common shares issued pursuant to the AIP that the executive, by accepting nonvested restricted common shares instead of cash, received in excess of the cash amount that the executive would have otherwise received. In 2024, the incremental aggregate grant date fair value of

#### 2025 Proxy StatementPage 54
nonvested restricted common shares issued pursuant to the AIP to Messrs. Silvers, Peterson, Zimmerman and Turvey and Ms. Mater was $1,192,425, $488,312, $467,508, $180,590 and $198,617, respectively. In 2024, Ms. Mater elected to receive $59,915 of her performance bonus in cash.

(4) The following table sets forth all other compensation for 2024, including amounts relating to personal use of company vehicles, the Company’s matching contributions under the Company’s 401(k) plan, amounts payable by the Company with respect to term life insurance premiums (and related tax gross-up payments), dividends paid on nonvested restricted shares that were not factored into the grant date fair value of such awards and payments for executive medical examinations.

| Name                 |     | Personal Use of Company Vehicles |        |     | 401(k)        
 Matching      
 Contributions |        |     | Term Life                         
 Insurance                         
 Premiums and Related Tax Gross-Up |        |     | Dividends |        |     | Executive Wealth and Financial Advice |       |     | Executive    
 Medical      
 Examinations |        |     | Total of All 
 Other        
 Compensation |         |
|:---------------------|